Stay updated on U3-1402 in NSCLC Clinical Trial
Sign up to get notified when there's something new on the U3-1402 in NSCLC Clinical Trial page.

Latest updates to the U3-1402 in NSCLC Clinical Trial page
- Check5 days agoChange DetectedThe page now displays the full U3-1402 study record for metastatic or unresectable non-small cell lung cancer, including detailed study methods, participant criteria, treatment arms, outcome measures, and participating locations. It also includes publication, record-history, and individual-participant-data sharing information.SummaryDifference97%

- Check12 days agoChange DetectedThe site footer revision changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check26 days agoChange DetectedAn NIH-wide notice about updated terminology for artificial intelligence was added to the page, and the site revision changed from v3.7.1 to v3.7.2.SummaryDifference1%

- Check40 days agoChange DetectedThe ClinicalTrials.gov footer revision label changes from v3.7.0 to v3.7.1 while the page continues to display a 403 error.SummaryDifference0.2%

- Check54 days agoChange DetectedRemoved access to several study documents and data-sharing references from the page, including the Informed Consent Form (ICF), IPD Sharing details, Statistical Analysis Plan (SAP), and the Study Protocol. This leaves the page focused on core study information while reducing quick access to supplementary materials.SummaryDifference21%

- Check61 days agoChange DetectedThe page now displays Revision: v3.7.0, replacing Revision: v3.6.6, indicating a minor site version update.SummaryDifference0.0%

Stay in the know with updates to U3-1402 in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the U3-1402 in NSCLC Clinical Trial page.